MTOR and nonpapillary renal cell carcinoma: Due to the implication of mTOR signaling in ccRCC progression and the use of mTOR inhibitor everolimus for the treatment of advanced ccRCC, we used the FunRich tool [57] to build the protein–protein interaction network between the 57 proteins on our list and the 52 proteins in the KEGG mTOR pathway.